LIPOSARCOMA OF THE HEAD AND NECK: THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER EXPERIENCE

被引:47
|
作者
Davis, Erica C. [1 ,2 ]
Ballo, Matthew T. [3 ]
Luna, Mario A. [4 ]
Patel, Shreyakurnar R. [5 ]
Roberts, Dianna B. [1 ]
Nong, Xiaolin [1 ]
Sturgis, Erich M. [1 ,6 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
关键词
head and neck neoplasms; sarcoma; liposarcoma; surgery; radiation; PLEOMORPHIC LIPOSARCOMA; REGION;
D O I
10.1002/hed.20923
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Our aim was to review our experience with liposarcoma of the head and neck region. Methods. This is a retrospective case series at a comprehensive cancer center (1945-2005). Results. Of 30 patients, 10 (33%) were initially misdiagnosed. Local recurrences were common (overall rate = 53%), and 4 patients (13%) developed distant metastases. Decreased crude disease-specific survival rates were significantly associated with recurrence (especially distant recurrence [0%]), age less than 38 years (40%), and pleomorphic subtype (45%); however, in Kaplan-Meier analyses, only larger tumor size, negative margins, round cell subtype, and pleomorphic subtype were associated with significantly decreased disease-specific survival (log-rank test p = .048, .041, .021, and .012, respectively). Conclusions. Based on this limited experience and existing literature, we continue to recommend surgery with negative margins as the treatment of choice and that adjuvant therapies should be considered in patients with high-grade histology, large tumors, positive margins, or certain subsites. (C) 2008 Wiley Periodicals, Inc. Head Neck 31: 28-36, 2009
引用
收藏
页码:28 / 36
页数:9
相关论文
共 50 条
  • [41] Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson Symptom Inventory, head and neck module
    Rosenthal, David I.
    Mendoza, Tito R.
    Chambers, Mark S.
    Asper, Joshua A.
    Gning, Ibrahima
    Kies, Merrill S.
    Weber, Randal S.
    Lewin, Jan S.
    Garden, Adam S.
    Ang, K. Kian
    Wang, Xin S.
    Cleeland, Charles S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (10): : 923 - 931
  • [42] Radical prostatectomy for lymph node positive prostate cancer: The M. D. Anderson Cancer Center experience
    Spiess, PE
    Busby, JE
    Jordan, J
    Hernandez, M
    Troncoso, P
    Burt, K
    Lee, AK
    Taylor, SH
    Merriman, KW
    Bassett, RL
    Pisters, LL
    JOURNAL OF UROLOGY, 2006, 175 (04): : 311 - 312
  • [43] Cytoreductive nephrectomy in the elderly patient: The M. D. Anderson cancer center experience - Editorial comment
    DeWolf, William C.
    JOURNAL OF UROLOGY, 2007, 177 (03): : 860 - 861
  • [44] INDUCTION TREATMENT FOR DIFFUSE INTRINSIC PONTINE GLIOMA, EXPERIENCE OF M. D. ANDERSON CANCER CENTER
    Wolff, Johannes
    Rytting, Michael
    Tribhawa, Vats
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 877 - 877
  • [45] Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center
    Komaki, R
    Roth, JA
    Walsh, GL
    Putnam, JB
    Vaporciyan, A
    Lee, JS
    Fossella, FV
    Chasen, M
    Delclos, ME
    Cox, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02): : 347 - 354
  • [46] The role of the electrocardiogram (ECG) in phase I drug development in patients with cancer: The University of Texas M. D. Anderson Cancer Center experience with 8,966 ECGs.
    Rodrigues, H. Veasey
    Naing, A.
    Hong, D. S.
    Falchook, G. S.
    Fu, S.
    Wheler, J. J.
    Tsimberidou, A. M.
    Moulder, S. L.
    Janku, F.
    Wen, S.
    Fessahaye, S. N.
    Golden, E. C.
    Westerhold, D. I.
    Ewer, M.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] The impact of clinical pathways on the practice of head and neck oncologic surgery - The University of Texas MD Anderson Cancer Center experience
    Chen, AY
    Callender, D
    Mansyur, C
    Reyna, KM
    Limitone, E
    Goepfert, H
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2000, 126 (03) : 322 - 326
  • [48] Imaging in oncology from the University of Texas M. D. Anderson Cancer Center - Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder
    Kundra, V
    Silverman, PM
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (04) : 1045 - 1054
  • [49] Phase I clinical trials in 85 patients with gynecologic cancer: The M. D. Anderson Cancer Center experience
    Moroney, John
    Wheler, Jennifer
    Hong, David
    Naing, Aung
    Falchook, Gerald
    Bodurka, Diane
    Coleman, Robert
    Lu, Karen
    Xiao, Lianchun
    Kurzrock, Razelle
    GYNECOLOGIC ONCOLOGY, 2010, 117 (03) : 467 - 472
  • [50] Clinical outcomes of patients with breast cancer in a phase I clinic: The M. D. Anderson Cancer Center experience
    Wheler, J. J.
    Tsimberidou, A.
    Moulder, S.
    Cristofanill, M.
    Hong, D.
    Naing, A.
    Pathak, R.
    Liu, S.
    Feng, L.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)